Efficacy of integrated Traditional Chinese Medicine and anti-retroviral therapy on immunological nonresponse in patients with human immunodeficiency virus/acquired immunodeficiency syndrome: a Meta-analysis of randomized controlled trial

• Published in: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan Vol. 41; no. 5; p. 669
• Main Authors: Tao, Zhuang, Huang, Xiao-Jie, Liu, Ying, Wang, Ru, Dong, Ji-Peng, Liang, Bi-Yan, Zou, Wen, Gao, Guo-Jian, Wang, Zhuo, Zhang, Ke, Wu, Hao, Zhang, Tong, Wang, Jian
• Format: Journal Article
• Language: English
• Published: China 01.10.2021
• Subjects: Acquired Immunodeficiency Syndrome - drug therapy; Drugs, Chinese Herbal - therapeutic use; HIV; Humans; Medicine, Chinese Traditional; Randomized Controlled Trials as Topic; Treatment Outcome; Immunological nonresponse; Meta- analysi; HIV; Medicine, Chinese Traditional; Acquired immunodeficiency syndrome; Anti-retroviral agent
• ISSN: 2589-451X

To explore the efficacy of integrating Traditional Chinese Medicine (TCM) and anti-retroviral therapy (ART), a customized combination of different classes of medications which was also called cock-tail treatment, on the immunological nonresponse (INR) in people living with human immunodeficiency virus (HIV) (PLWH). Relevant literature in databases such as China National Knowledge Infrastructure Database (CNKI), Wanfang Digital Journal, Chinese Medical Journal Database (CMJD), Chinese Biomedical Literature Database (CBM), PubMed, Cochrane, and Embase was reviewed by two independent investigators. Data were extracted from the studies according to the eligible criteria and analyzed using Review Manager 5.3. Nine randomized controlled trials (RCTs) with 1078 patients were analyzed. Our analyses showed that CD4 T cell counts in the treatment group improved compared with that in the control group [mean difference (MD) = 13.51, 95% confidence interval (CI): 7.42-19.60, P < 0.0001]. There was no significant difference between the treated and control groups after 3 months (MD = 25.31, 95% CI: ?2.78 to 53.41, P = 0.08). However, after 6 and 12 months, the response of the treatment group was superior to the control group (MD = 27.45, 95% CI: 7.09-47.81, P = 0.008 and MD = 27.34, 95% CI: 6.31-48.37, P = 0.01, respectively). The clinical efficacy of the treatment group was also higher than that of the control group (RR = 1.75, 95% CI: 1.16-2.65, P = 0.007). However, CD45RO and CD45RA T cell counts did not differ significantly between the two groups (MD = 12.37, 95% CI: ?6.71 to 31.45, P = 0.20 and MD = 5.67, 95% CI: ?3.00 to14.35, P = 0.20, respectively). The combined treatment strategy of integrated TCM and Western Medicine promotes long-term reconstitution of the immune system and thus, is beneficial and has potential use for improving INR in PLWH. However, large-scale RCTs are required to provide evidence for optimal intervention strategies.